Soberana Plus was conceived for convalescent patients

Convalescents from COVID-19 in Las Tunas, who fell ill before July 25, have benefited from this Sunday with a single dose of the Cuban Soberana Plus vaccine, which has demonstrated its safety and ability to stimulate the immunity developed by patients as a consequence of the natural infection.

Vaccination against COVID-19 continues

As the mass vaccination takes place in Las Tunas, concerns arise in the population, above all, about those who have not received yet the doses of Cuban vaccines or complete the schedule, due to suffering from an acute disease at the time they are it corresponded, present respiratory symptoms, or some decompensated chronic illness, among other exclusion criteria.

The Center for Genetic Engineering and Biotechnology (CIGB) reported that its Abdala Covid-19 vaccine has an efficacy rate of 90%The Center for Genetic Engineering and Biotechnology (CIGB) reported that its Abdala Covid-19 vaccine has an efficacy rate of 90% in seriously ill patients affected by the SARS-CoV-2 virus, according to local media.

Mipcr app

For just over a week, an Android application has been running in Las Tunas, through which it is possible to consult the results of the PCR tests, which makes it possible to socialize the information more quickly, benefiting the population and the health system.